Status report
Get it in writing
The official USPTO status record for GABITRIL, serial 75048016, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
GABITRILSerial 75048016 · Principal Register
Live · Registered
Owner: CEPHALON LLC
Class 005 - Pharmaceuticals
Filed Jan 24, 1996
Registered May 05, 1998
The record shows that “GABITRIL” is a live, registered mark on the Principal Register, owned by CEPHALON LLC, a Delaware limited liability company. It protects a pharmaceutical preparation for treating neurological disorders, the only goods listed. A similar name would raise the closest concern in the same pharmaceutical category, especially for neurological treatments. The record does not give the owner control over every use of the word “Gabitril” in unrelated contexts. The mark was registered on May 5 1998 and has been renewed, with the most recent renewal event noted on May 14 2018. No opposition, cancellation, or enforcement actions appear in the supplied history, so the record shows no visible enforcement activity. For anyone considering a similar name, the primary risk lies in the pharmaceutical field for neurological disorders, where this mark’s active status could create a meaningful concern.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.